are compounding pharmacies still making tirzepatide Compounded and 503A – Town & Country Compounding FDA Says Compounding Pharmacies Can

An increased ratio of Firmicutes to Bacteroidetes results in a weakened intestinal mucosal barrier, which promotes the passage of bacteria into the bloodstream and leads to chronic inflammation

& Kepinska, M

While it is generally safe for short-term use, the long-term effects are not well understood

That approach works until subtle hunger cues disappear and hydration and nutrient intake fragment, which can lead to weakness, nutrient gaps, and avoidable side effects

GLP-1 receptor activation also influences fluid and electrolyte secretion in the intestinal mucosa, which may contribute to changes in stool consistency